Diagnosis of megaloblastic anaemias

Blood Reviews

Volumn 20, Issue 6, 2006, Pages 299-318

  Wickramasinghe, S N ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

B12 deficiency; Diagnosis; Folate deficiency; Inborn errors of metabolism; Megaloblastic anaemia

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; ANTICONVULSIVE AGENT; ATTAPULGITE; BIGUANIDE DERIVATIVE; COLCHICINE; COLESTYRAMINE; COTRIMOXAZOLE; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; CYCLOSERINE; DIHYDROFOLATE REDUCTASE INHIBITOR; FOLIC ACID; GLUTETHIMIDE; HAPTOCORRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HOMOCYSTEINE; HYDROXYUREA; METFORMIN; METHYLMALONIC ACID; NEOMYCIN; ORAL CONTRACEPTIVE AGENT; PHENFORMIN; POTASSIUM CHLORIDE; PROCARBAZINE; PROTON PUMP INHIBITOR; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SALAZOSULFAPYRIDINE; THIAMINE; TRANSCOBALAMIN II; UNINDEXED DRUG;

ACIDURIA; ALCOHOLISM; ARTICLE; BLOOD CELL COUNT; BLOOD LEVEL; CELL METABOLISM; CLINICAL FEATURE; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 1; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 3; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC TEST; DIET; DISEASE COURSE; DRUG ABSORPTION; DRUG METABOLISM; DRUG TRANSPORT; EARLY DIAGNOSIS; EPILEPSY; ERYTHROCYTE; ERYTHROLEUKEMIA; ERYTHROPOIESIS; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILEUM RESECTION; LESCH NYHAN SYNDROME; MALABSORPTION; MEGALOBLASTIC ANEMIA; METABOLIC DISORDER; METABOLITE; METHYLMALONIC ACIDEMIA; MYELODYSPLASTIC SYNDROME; NUCLEIC ACID SYNTHESIS; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PANCREAS FUNCTION; PARTIAL GASTRECTOMY; PERNICIOUS ANEMIA; PLASMA; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEINURIA; SENSITIVITY AND SPECIFICITY; SERUM; SMALL INTESTINE ABSORPTION; TOTAL STOMACH RESECTION; TROPICAL SPRUE; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

ANEMIA, MEGALOBLASTIC; FOLIC ACID DEFICIENCY; HUMANS; TRANSCOBALAMINS; VITAMIN B 12 DEFICIENCY;

EID: 33750620935     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2006.02.002     Document Type: Article

References (113)

1. 12, serum folate and red cell folate. In: Rowan R.M., van Assendelft O.W., and Preston F.E. (Eds). Advanced Laboratory Methods in Haematology (2002), Arnold, London 264-289
2. Lindenbaum J., Savage D.G., Stabler S.P., and Allen R.H. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 34 (1990) 99-107
3. Carmel R., Green R., Jacobsen D.W., Rasmussen K., Florea M., and Azen C. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: Ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr 70 (1999) 904-910
4. Carmel R., Green R., Rosenblatt D.S., and Watkins D. Update on cobalamin, folate, and homocysteine. Hematology (Am Soc Hematol Educ Program) (2003) 62-81
5. Carmel R. Mild transcobalamin I (haptocorrin) deficiency and low serum cobalamin concentrations. Clin Chem 49 (2003) 1367-1374
6. Savage D.G., Lindenbaum J., Stabler S.P., and Allen R.H. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 96 (1994) 239-246
7. Allen R.H., Stabler S.P., Savage D.G., and Lindenbaum J. Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations. Amer J Hematol 4 (1990) 90-98
8. Wickramasinghe S.N., and Ratnayaka I.D. Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocytosis. J Clin Pathol 49 (1996) 755-758
9. Miller J.W., Garrod M.G., Rockwood A.L., Kushnir M.M., Allen L.H., Haan M.N., et al. Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin Chem (2005) Dec 29; Epub ahead of print
10. Hvas A.M., and Nexo E. Holotranscobalamin as a predictor of vitamin B12 status. Clin Chem Lab Med 41 (2003) 1489-1492
11. Herrmann W., Obeid R., Schorr H., and Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 41 (2003) 1478-1488
12. Nilsson K., Isaksson A., Gustafson L., and Hultberg B. Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms. Clin Chem Lab Med 42 (2004) 637-643
13. Herrmann W., Obeid R., Schorr H., and Geisel J. The usefulness of holotranscobalamin in predicting vitamin B12 status in different clinical settings. Curr Drug Metab 6 (2005) 47-53
14. Chen X., Remacha A.F., Sarda M.P., and Carmel R. Influence of cobalamin deficiency compared with that of cobalamin absorption on serum holo-transcobalamin II. Am J Clin Nutr 81 (2005) 110-114
15. Metz J., Kelly A., Swett V.C., Waxman S., and Herbert V. Deranged DNA synthesis by bone marrow from vitamin B-12-deficient humans. Br J Haematol 14 (1968) 575-592
16. Wickramasinghe S.N. The deoxyuridine suppression test: a review of its clinical and research applications. Clin Lab Haematol 3 (1981) 1-18
17. Wickramasinghe S.N., and Matthews J.H. Deoxyuridine suppression: biochemical basis and diagnostic applications. Blood Rev 2 (1988) 168-177
18. Carmel R., Rasmussen K., Jacobsen D.W., and Green R. Comparison of the deoxyuridine suppression test with serum levels of methylmalonic acid and homocysteine in mild cobalamin deficiency. Br J Haematol 93 (1996) 311-318
19. Chanarin I. The megaloblastic anaemias. third ed. (1990), Blackwell Scientific Publications, Oxford
20. Jones P., Grace C.S., and Rozenberg M.C. Interpretation of serum and red cell folate results. A comparison of microbiological and radioisotopic methods. Pathology 11 (1979) 45-52
21. Jaffe J.P., and Schilling R.F. Erythrocyte folate levels: a clinical study. Am J Hematol 36 (1991) 116-121
22. Phekoo K., Williams Y., Schey S.A., Andrews V.E., Dudley J.M., and Hoffbrand A.V. Folate assays: Serum or red cell?. J R Coll Physicians Lond 31 (1997) 291-295
23. Owen W.E., and Roberts W.L. Comparison of five automated serum and whole blood folate assays. Am J Clin Pathol 120 (2003) 121-126
24. Clifford A.J., Noceti E.M., Block-Joy A., Block T., and Block G. Erythrocyte folate and its response to folic acid supplementation is assay dependent in women. J Nutr 135 (2005) 137-143
25. Bain B.J., Wickramasinghe S.N., Broom G.N., Litwinczuk R.A., and Sims J. Assessment of the value of a competitive protein binding radioassay of folic acid in the detection of folic acid deficiency. J Clin Pathol 37 (1984) 888-894
26. Schwartz S.O., Kaplan S.R., and Armstrong B.E. The long-term evaluation of folic acid in the treatment of pernicious anemia. J Lab Clin Med 35 (1950) 894-898
27. Carmel R. Pernicious anemia. The expected findings of very low serum cobalamin levels, anemia and macrocytosis are often lacking. Arch Intern Med 148 (1988) 1712-1714
28. 12 deficiency. Acta haematol 81 (1989) 186-191
29. Stabler S.P., Allen R.H., Savage D.G., and Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 76 (1990) 871-881
30. Healton E.B., Savage D.G., Brust J.C.M., Garrett T.J., and Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine 70 (1991) 229-245
31. Lindenbaum J., Healton E.B., Savage D.G., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. New Engl J Med 318 (1988) 1720-1728
32. Donnelly S., and Callaghan N. Subacute combined degeneration of the spinal cord due to folate deficiency in association with a psychotic illness. Ir Med J 83 (1990) 73-74
33. Parry T.E. Folate responsive neuropathy. Presse Med 23 (1994) 131-137
34. Ravakhah K., and West B.C. Case report: subacute combined degeneration of the spinal cord from folate deficiency. Am J Med Sci 310 (1995) 214-216
35. Guettat L., Gille M., Delbecq J., and Depre A. Folic acid deficiency with leukoencephalopathy and chronic axonal neuropathy of sensory predominance. Rev Neurol (Paris) 153 (1997) 351-353
36. Hsu C.T., Miller N.R., and Wray M.L. Optic neuropathy from folic acid deficiency without alcohol abuse. Ophthalmologica 216 (2002) 65-67
37. Morris M.S., Fava M., Jacques P.F., Selhub J., and Rosenberg I.H. Depression and folate status in the US Population. Psychother Psychosom 72 (2003) 80-87
38. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1103-1112
39. Koebnick C., Hoffmann I., Dagnelie P.C., Heins U.A., Wickramasinghe S.N., Ratnayaka I.D., et al. Long-term ovo-lacto vegetarian diet impairs vitamin B-12 status in pregnant women. J Nutr 134 (2004) 3319-3326
40. Herbert V. The 1986 Herman Award Lecture. Nutrition science as a continually unfolding story: The folate and vitamin B-12 paradigm. Am J Clin Nutr 46 (1987) 387-402
41. Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr 59 Suppl (1994) 1213S-1222S
42. Carmel R. Subtle cobalamin deficiency. In: Bhatt H.R., James V.H.T., Besser G.M., et al. (Eds). Advances in Thomas Addison's Diseases vol 1 (1994), Journal of Endocrinology Ltd, Bristol 281-294
43. Herrmann W., Schorr H., Obeid R., and Geisel J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr 78 (2003) 131-136
44. Korenke G.C., Hunneman D.H., Eber S., and Hanefeld F. Severe encephalopathy with epilepsy in an infant caused by subclinical maternal pernicious anaemia: Case report and review of the literature. Eur J Pediatr 163 (2004) 196-201
45. Gutierrez-Aguilar G., Abenia-Uson P., Garcia-Cazorla A., Vilaseca M.A., and Campistol J. Encephalopathy with methylmalonic aciduria and homocystinuria secondary to a deficient exogenous supply of vitamin B12. Rev Neurol 40 (2005) 605-608
46. Doscherholmen A., McMahon J., and Ripley D. Vitamin B12 assimilation from chicken meat. Am J Clin Nutr 31 (1978) 825-830
47. Carmel R., Sinow R.M., Siegel M.E., and Samloff I.M. Food cobalamin malabsorption occurs frequently in patients with unexplained low serum cobalamin levels. Arch Intern Med 148 (1988) 1715-1719
48. 12 levels. Am J Hematol 40 (1992) 163-166
49. Carmel R. Cobalamin, the stomach, and aging. Am J Clin Nutr 66 (1997) 750-759
50. 12. Br Med J 288 (1984) 675-678
51. Carmel R., Sinow R.M., and Karnaze D.S. Atypical cobalamin deficiency. Subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with protein-bound cobalamin malabsorption. J Lab Clin Med 109 (1987) 454-463
52. Jones B.P., Broomhead A.F., Kwan Y.L., and Grace C.S. Incidence and clinical significance of protein-bound vitamin B12 malabsorption. Eur J Haematol 38 (1987) 131-136
53. Karnaze D.S., and Carmel R. Neurologic and evoked potential abnormalities in subtle cobalamin deficiency states, including deficiency without anemia and with normal absorption of free cobalamin. Arch Neurol 47 (1990) 1008-1012
54. Carmel R., Gott P.S., Waters C.H., Cairo K., Green R., Bondareff W., et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol 54 (1995) 245-253
55. King C.E., and Toskes P.P. Evolution of protein-bound cobalamin malabsorption. Arch Intern Med 143 (1983) 2219
56. Andres E., Noel E., Henoun Loukili N., Coca C., Vinzio S., and Blickle J.F. Is there a link between the food-cobalamin malabsorption and the pernicious anemia?. Ann Endocrinol (Paris) 65 (2004) 118-120
57. Andres E., Affenberger S., Vinzio S., Kurtz J.E., Noel E., Kaltenbach G., et al. Food-cobalamin malabsorption in elderly patients: Clinical manifestations and treatment. Am J Med 118 (2005) 1154-1159
58. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 51 (2000) 357-375
59. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 156 (1996) 1097-1100
60. Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol 90 (1988) 442-445
61. Kekki M., Samloff I.M., Varis K., and Ihamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl 186 (1991) 109-116
62. Carmel R. Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: Influence of patient age and race. Clin Exp Immunol 89 (1992) 74-77
63. Carmel R. Gastric juice in congenital pernicious anemia contains no immunoreactive intrinsic factor molecule: Study of three kindreds with variable ages at presentation, including a patient first diagnosed in adulthood. Am J Hum Genet 35 (1983) 67-77
64. Rosenblatt D., and Fenton W.A. Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The metabolic & molecular bases of inherited disease. Eighth ed. (2001), McGraw-Hill, New york 3897-3933
65. Gordon M.M., Brada N., Remacha A., Badell I., del Rio E., Baiget M., et al. A genetic polymorphism in the coding region of the gastric intrinsic factor gene (GIF) is associated with congenital intrinsic factor deficiency. Hum Mutat 23 (2004) 85-91
66. Tanner S.M., Li Z., Perko J.D., Oner C., Cetin M., Altay C., et al. Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene. Proc Natl Acad Sci U S A 102 (2005) 4130-4133
67. Katz M., Mehlman C.S., and Allen R.H. Isolation and characterization of an abnormal human intrinsic factor. J Clin Invest 53 (1974) 1274-1283
68. Yang Y.M., Ducos R., Rosenberg A.J., Catrou P.G., Levine J.S., Podell E.R., et al. Cobalamin malabsorption in three siblings due to an abnormal intrinsic factor that is markedly susceptible to acid and proteolysis. J Clin Invest 76 (1985) 2057-2065
69. Dupouy-Camet J., and Peduzzi R. Current situation of human diphyllobothriasis in Europe. Euro Surveill 9 (2004) 31-35
70. Fyfe J.C., Madsen M., Hojrup P., Christensen E.I., Tanner S.M., de la Chapelle A., et al. The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood 103 (2004) 1573-1579
71. Tanner S.M., Li Z., Bisson R., Acar C., Oner C., Oner R., et al. Genetically heterogeneous selective intestinal malabsorption of vitamin B12: Founder effects, consanguinity, and high clinical awareness explain aggregations in Scandinavia and the Middle East. Hum Mutat 23 (2004) 327-333
72. Burkes R.L., Cohen H., Krailo M., Sinow R.M., and Carmel R. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol 38 (1987) 141-147
73. Remacha A.F., Riera A., Cadafalch J., and Gimferrer E. Vitamin B-12 abnormalities in HIV-infected patients. Eur J Haematol 47 (1991) 60-64
74. Paltiel O., Falutz J., Veilleux M., Rosenblatt D.S., and Gordon K. Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus. Am J Hematol 49 (1995) 318-322
75. Remacha A.F., and Cadafalch J. Cobalamin deficiency in patients infected with the human immunodeficiency virus. Semin Hematol 36 (1999) 75-87
76. Herzlich B.C., Schiano T.D., Moussa Z., Zimbalist E., Panagopoulos G., Ast A., et al. Decreased intrinsic factor secretion in AIDS: Relation to parietal cell acid secretory capacity and vitamin B12 malabsorption. Am J Gastroenterol 87 (1992) 1781-1788
77. Chanarin I. Cobalamins and nitrous oxide: A review. J Clin Pathol 33 (1980) 909-916
78. Layzer R.B. Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet ii (1978) 1227-1230
79. Nunn J.F., Sharer N.M., Gorchein A., Jones J.A., and Wickramasinghe S.N. Megaloblastic haemopoiesis after multiple short-term exposure to nitrous oxide. Lancet i (1982) 1379-1381
80. Diamond A.L., Diamond R., Freedman S.M., and Thomas F.P. "Whippets"-induced cobalamin deficiency manifesting as cervical myelopathy. J Neuroimaging 14 (2004) 277-280
81. Doran M., Rassam S.S., Jones L.M., and Underhill S. Toxicity after intermittent inhalation of nitrous oxide for analgesia. Br Med J 328 (2004) 1364-1365
82. Burman J.F., Mollin D.L., Sourial N.A., and Sladden R.A. Inherited lack of transcobalamin II in serum and megaloblastic anaemia: A further patient. Br J Haematol 43 (1979) 27-38
83. Hall C.A. The neurologic aspects of transcobalamin II deficiency. Br J Haematol 80 (1992) 117-120
84. Kaikov Y., Wadsworth L.D., Hall C.A., and Rogers P.C. Transcobalamin II deficiency: Case report and review of the literature. Eur J Pediatr 150 (1991) 841-843
85. Haurani F.I., Hall C.A., and Rubin R. Megaloblastic anemia as a result of an abnormal transcobalamin II (Cardoza). J Clin Invest 64 (1979) 1253-1259
86. Seligman P.A., Steiner L.L., and Allen R.H. Studies of a patient with megaloblastic anemia and an abnormal transcobalamin II. N Engl J Med 303 (1980) 1209-1212
87. Qian L., Quadros E.V., Regec A., Zittoun J., and Rothenberg S.P. Congenital transcobalamin II deficiency due to errors in RNA editing. Blood Cells Mol Dis 28 (2002) 134-142 discussion 143-5
88. Namour F., Helfer A.-C., Quadros E.V., Alberto J.-M., Bibi H.M., Orning L., et al. Transcobalamin deficiency due to activation of an intra exonic cryptic splice site. Br J Haematol 123 (2003) 915-920
89. Linnell J.C., and Bhatt H.R. Inherited errors of cobalamin metabolism and their management. Bailliere's Clin Haematol 8/3 (1995) 567-601
90. Green R., and Miller J.W. Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med 43 (2005) 1048-1051
91. Scott J.M., and Weir D.G. Drug-induced megaloblastic change. Clin Haematol 9 (1980) 587-606
92. Reynolds E.H., and Laundy M. Haematological effects of anticonvulsant treatment. Lancet ii (1978) 682
93. Sutterlin M.W., Bussen S.S., Rieger L., Dietl J., and Steck T. Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol. Eur J Obstet Gynecol Reprod Biol 107 (2003) 57-61
94. Green T.J., Houghton L.A., Donovan U., Gibson R.S., and O'Connor D.L. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. J Am Diet Assoc 98 (1998) 49-55
95. Gardyn J., Mittelman M., Zlotnik J., Sela B.A., and Cohen A.M. Oral contraceptives can cause falsely low vitamin B(12) levels. Acta Haematol 104 (2000) 22-24
96. Zittoun J. Congenital errors of folate metabolism. Bailliere's Clin Haematol 8/3 (1995) 603-616
97. Hilton J.F., Christensen K.E., Watkins D., Raby B.A., Renaud Y., de la Luna S., et al. The molecular basis of glutamate formiminotransferase deficiency. Hum Mutat 22 (2003) 67-73
98. Girot R., Hamet M., Perignon J.-L., Guesnu M., Fox R.M., Cartier P., et al. Cellular immune deficiency in two siblings with hereditary orotic aciduria. N Engl J Med 308 (1983) 700-704
99. Nyhan W.L. Disorders of purine and pyrimidine metabolism. Mol Genet Metab 86 (2005) 25-33
100. Suchi M., Mizuno H., Kawai Y., Tsuboi T., Sumi S., Okajima K., et al. Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families. Am J Hum Genet 60 (1997) 525-539
101. Salerno C., and Crifo C. Diagnostic value of urinary orotic acid levels: Applicable separation methods. J Chromatogr B Analyt Technol Biomed Life Sci 781 (2002) 57-71
102. Nyhan W.L. The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism. J Inherit Metab Dis 20 (1997) 171-178
103. Nyhan W.L. Lesch-Nyhan Disease. J Hist Neurosci 14 (2005) 1-10
104. van der Zee S.P.M., Schretlen E.D.A.M., and Monnens L.A.H. Megaloblastic anaemia in the Lesch-Nyhan syndrome. (Letter) Lancet i (1968) 1427
105. Cossu A., Orru S., Jacomelli G., Carcassi C., Contu L., Sestini S., et al. HPRT (Sardinia): A new point mutation causing HPRT deficiency without Lesch-Nyhan disease. Biochim Biophys Acta 1762 (2005) 29-33
106. Wickramasinghe S.N., and Hasan R. Possible role of macrophages in the pathogenesis of ethanol-induced bone marrow damage. Br J Haematol 83 (1993) 574-579
107. Wickramasinghe S.N. Role of macrophages in the pathogenesis of alcohol-induced tissue damage. Br Med J 294 (1987) 1137-1139
108. Wickramasinghe S.N., Gardner B., and Barden G. Circulating cytotoxic protein generated after ethanol consumption: Identification and mechanism of reaction with cells. Lancet ii (1987) 122-126
109. Wickramasinghe S.N., and Wood W.G. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol 131 (2005) 431-446
110. Haworth C., Evans D.I.K., Mitra J., and Wickramasinghe S.N. 1982 Thiamine responsive anaemia: A study of two further cases. Br J Haematol 50 (1982) 549-561
111. Fleming J.C., Tartaglini E., Steinkamp M.P., Schorderet D.F., Cohen N., and Neufeld E.J. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat Genet 22 (1999) 305-308
112. Diaz G.A., Banikazemi M., Oishi K., Desnick R.J., and Gelb B.D. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet 22 (1999) 309-312
113. Labay V., Raz T., Baron D., Mandel H., Williams H., Barrett T., et al. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet 22 (1999) 300-304